Pharma
FDA’s fast track process is under fire
The fast-lane approval process has raised concerns about oversight.
The fast-lane approval process has raised concerns about oversight.
President Trump signed a number of executive orders soon after taking office, including a WHO withdrawal and overturning ACA policies.
Experts share what they’re looking forward to in the new year following the FDA’s rejection of a psychedelic therapy.
The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.
The drugmaker said it hopes the move will ease supply constraints and increase patient access.
What do we want? Medicare coverage! When do we want it? Now!
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.